Effects of raloxifene on bone metabolism in postmenopausal women on chronic hemodialysis

被引：0
|
作者：
Katsuyuki Nagatoya
Kazuhiko Nishimoto
Nobuhisa Shibahara
Toshikazu Takahashi
Hironori Kanehara
Nobuyuki Ueno
Hideaki Yasuda
Shigeki Okada
Haruhiko Ueda
Kei Hirai
Toru Inoue
机构：
[1] Osaka Medical College Hospital,Blood Purification Center
[2] Osaka Rosai Hospital,Department of Laboratory Medicine
[3] Nishimoto Clinic,Department of Nephrology
[4] Arisawa General Hospital,Department of Internal Medicine
[5] Takatsuki General Hospital,undefined
[6] Kanehara Clinic,undefined
[7] Sanko Clinic,undefined
[8] Sanko Fuzoku Clinic,undefined
[9] Okada Clinic,undefined
[10] Kamo Hospital,undefined
[11] Sanko Clinic,undefined
[12] General Hospital Higashikouri,undefined
来源：
Clinical and Experimental Nephrology | 2015年 / 19卷
关键词：
Postmenopausal woman; End-stage renal failure; Raloxifene; Bone metabolism; Vitamin D;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：939 / 946
页数：7
相关论文
共 50 条
  • [31] Bone mineral density in postmenopausal women treated with raloxifene
    Danckers, LF
    Danckers, M
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2003, 10 (06): : 607 - 607
  • [32] Effects of raloxifene on bone density and biochemical markers of bone remodeling in postmenopausal women with osteoporosis and diabetes
    Lunar, L
    Serafin, M
    Da Silva, R
    Machado, M
    Gonzales, A
    Alfonzo, S
    OSTEOPOROSIS INTERNATIONAL, 2004, 15 : S135 - S135
  • [33] Effect of raloxifene, a selective estrogen receptor modulator (SERM), on bone resorption markers and serum lipids in postmenopausal women on chronic hemodialysis (HD)
    Hernandez, E
    Valera, R
    Teran, J
    Bajares-Lilue, M
    Capriles, F
    Alonzo, E
    de Elquezabal, K
    Carlini, R
    Bellorin-Font, E
    Weisinger, JR
    BONE, 2001, 28 (05) : S233 - S233
  • [34] Effects of raloxifene and alendronate on bone mineral density and bone turnover markers in postmenopausal women with osteoporosis
    Johnell, O
    Lu, Y
    Seeman, E
    Reginster, J
    Scheele, W
    OSTEOPOROSIS INTERNATIONAL, 2000, 11 : S184 - S184
  • [35] Neuroendocrine effects of raloxifene hydrochloride in postmenopausal women
    Florio, P
    Quirici, B
    Casarosa, E
    Lombardi, I
    Luisi, M
    Genazzani, AD
    Petraglia, F
    Genazzani, AR
    GYNECOLOGICAL ENDOCRINOLOGY, 2001, 15 (05) : 359 - 366
  • [36] Effects of raloxifene hydrochloride on the endometrium of postmenopausal women
    Boss, SM
    Huster, WJ
    Neild, JA
    Glant, MD
    Eisenhut, CC
    Draper, MW
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1997, 177 (06) : 1458 - 1464
  • [37] The Effects of Tualang Honey on Bone Metabolism of Postmenopausal Women
    Effendy, Nadia Mohd
    Mohamed, Norazlina
    Muhammad, Norliza
    Mohamad, Isa Naina
    Shuid, Ahmad Nazrun
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2012, 2012
  • [38] Effects of raloxifene on lumbar BMD and bone markers in postmenopausal osteoporotic Korean women.
    Joo, I
    Bae, T
    Oh, H
    JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (09) : S172 - S172
  • [39] Comparative effects of raloxifene and alendronate on fracture outcomes in postmenopausal women with low bone mass
    Recker, Robert R.
    Kendler, David
    Recknor, Christopher P.
    Rooney, Theodore W.
    Lewiecki, E. Michael
    Utian, Wulf H.
    Cauley, Jane A.
    Lorraine, Joanne
    Qu, Yongming
    Kulkarni, Pandurang M.
    Gaich, Carol L.
    Wong, Mayme
    Plouffe, Leo, Jr.
    Stock, John L.
    BONE, 2007, 40 (04) : 843 - 851
  • [40] A comparison of the effects of raloxifene and conjugated equine estrogen on bone and lipids in healthy postmenopausal women
    Reid, IR
    Eastell, R
    Fogelman, I
    Adachi, JD
    Rosen, A
    Netelenbos, C
    Watts, NB
    Seeman, E
    Ciaccia, AV
    Draper, MW
    ARCHIVES OF INTERNAL MEDICINE, 2004, 164 (08) : 871 - 879
12345